Autobio Diagnostics Co Ltd
SSE:603658

Watchlist Manager
Autobio Diagnostics Co Ltd Logo
Autobio Diagnostics Co Ltd
SSE:603658
Watchlist
Price: 44.2 CNY -6.04% Market Closed
Market Cap: 25.3B CNY
Have any thoughts about
Autobio Diagnostics Co Ltd?
Write Note

Autobio Diagnostics Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Autobio Diagnostics Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Autobio Diagnostics Co Ltd
SSE:603658
Cash from Investing Activities
-ÂĄ435m
CAGR 3-Years
48%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Cash from Investing Activities
-ÂĄ1.6B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Cash from Investing Activities
ÂĄ32.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Cash from Investing Activities
ÂĄ1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Cash from Investing Activities
-ÂĄ290.7m
CAGR 3-Years
51%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Intco Medical Technology Co Ltd
SZSE:300677
Cash from Investing Activities
-ÂĄ4B
CAGR 3-Years
26%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
No Stocks Found

Autobio Diagnostics Co Ltd
Glance View

Market Cap
25.7B CNY
Industry
Health Care

Autobio Diagnostics Co., Ltd. engages in the research, development, manufacturing, integration, service, and distribution of in vitro diagnostic reagents and instruments. The company is headquartered in Zhengzhou, Henan and currently employs 5,031 full-time employees. The company went IPO on 2016-09-01. The firm's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The firm distributes its products in domestic markets.

Intrinsic Value
78.4 CNY
Undervaluation 44%
Intrinsic Value
Price

See Also

What is Autobio Diagnostics Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-435m CNY

Based on the financial report for Jun 30, 2024, Autobio Diagnostics Co Ltd's Cash from Investing Activities amounts to -435m CNY.

What is Autobio Diagnostics Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
4%

Over the last year, the Cash from Investing Activities growth was 67%. The average annual Cash from Investing Activities growth rates for Autobio Diagnostics Co Ltd have been 48% over the past three years , 4% over the past five years .

Back to Top